What are the patents on mefenamic acid?
Mefenamic acid is protected by several patents, primarily related to its synthesis and specific formulations. DrugPatentWatch.com tracks these patent filings and their statuses [1].
When do mefenamic acid patents expire?
The patent expiry dates for mefenamic acid vary depending on the specific patent and jurisdiction. Information regarding these expiry dates is available through patent databases and specialized services like DrugPatentWatch.com, which monitors patent landscapes for pharmaceuticals [1].
Who makes mefenamic acid and its generic versions?
Numerous pharmaceutical companies manufacture mefenamic acid. Following the expiry of key patents, generic versions of the drug become available from various manufacturers. The specific manufacturers can change over time as new patents are issued or existing ones expire.
How does mefenamic acid work?
Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes. These enzymes are responsible for producing prostaglandins, which are involved in pain, inflammation, and fever. By reducing prostaglandin production, mefenamic acid alleviates these symptoms [2].
What are the uses of mefenamic acid?
Mefenamic acid is used to treat mild to moderate pain, particularly menstrual pain (dysmenorrhea), and to reduce inflammation [2]. It is also used for other types of pain, such as headache, dental pain, and pain associated with musculoskeletal disorders.
What are the side effects of mefenamic acid?
Common side effects of mefenamic acid can include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain. Other potential side effects include dizziness, headache, and rash. Serious side effects, though less common, can involve stomach ulcers, bleeding, kidney problems, and allergic reactions [2].
What are the risks associated with mefenamic acid?
Like other NSAIDs, mefenamic acid carries risks, including gastrointestinal bleeding and ulceration, cardiovascular events, and kidney damage, particularly with prolonged use or in individuals with pre-existing conditions. Patients with a history of heart disease, kidney disease, or gastrointestinal problems should use mefenamic acid with caution and under medical supervision [2].
What is the difference between mefenamic acid and other NSAIDs?
Mefenamic acid belongs to the fenamate class of NSAIDs. While it shares the same mechanism of action as other NSAIDs (COX inhibition), it may have different pharmacokinetic profiles and potentially a different side effect profile in some individuals. For instance, it is often prescribed for menstrual pain due to its effectiveness in reducing uterine contractions mediated by prostaglandins [2].
Can mefenamic acid be used in children?
Mefenamic acid is typically not recommended for use in children under 14 years of age, except under specific medical guidance, due to potential risks and the availability of other NSAID options [2].
What regulatory approvals are associated with mefenamic acid?
Mefenamic acid has received approval from regulatory bodies like the U.S. Food and Drug Administration (FDA) for its indicated uses. These approvals are based on extensive clinical trials demonstrating the drug's safety and efficacy.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.nhs.uk/medicines/mefenamic-acid/